passages.id: 135
passages.type: sentence
passages.text: To compare maintenance epoetin alfa administered once every 3 weeks with continued weekly epoetin alfa for patients with cancer-associated anemia .
entities.id: 136
entities.type: intervention
entities.text: epoetin alfa
entities.id: 137
entities.type: intervention
entities.text: epoetin alfa
entities.id: 138
entities.type: participant
entities.text: patients with cancer-associated anemia